Home/ Supplements/ Vitamin A/ Proteozyme Forte

Proteozyme Forte

product on market Tablet or Pill Douglas Laboratories Safety: 87/100
87/100

This product is generally safe

  • Zinc: 75mg is 1.9× the Tolerable Upper Intake Level (40mg)
  • Manganese: 150mg is 13.6× the Tolerable Upper Intake Level (11mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 40% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The profile contains essential B vitamins and antioxidants, which have strong evidence for supporting cellular energy metabolism and immune function. However, the overall evidence coverage for this specific formulation is limited. The ingredients are generally recognized as safe at standard dosages.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Zinc: 75mg is 1.9× the Tolerable Upper Intake Level (40mg)

Manganese: 150mg is 13.6× the Tolerable Upper Intake Level (11mg)

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Proteozyme Forte
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
1000 IU (20% DV)
Vitamin C
500 mg (833% DV)
10 mg (667% DV)
8.3× RDA — above typical dose 76 studies (A:0, B:33)
10 mg (588% DV)
7.7× RDA — above typical dose 13 studies (A:0, B:1)
10 mg (50% DV)
Within RDA (0.7× RDA) 196 studies (A:5, B:63)
50 mg (2500% DV)
38.5× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
200 mcg (50% DV)
Within RDA (0.5× RDA) 226 studies (A:10, B:105)
50 mcg (833% DV)
20.8× RDA — above typical dose 139 studies (A:1, B:44)
50 mg (500% DV)
10.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
150 mg (15% DV)
75 mg (19% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
75 mg (500% DV)
Exceeds UL by 1.9× (UL: 40 mg) 263 studies (A:6, B:134)
150 mg (7500% DV)
Exceeds UL by 13.6× (UL: 11 mg) 9 studies — no high-quality reviews
Potassium
75 mg (2% DV)
Market median: 2000.0mg (63 products)
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
2500 MCU
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews
Trypsin
100 mg
Market median: 1000.0mg (1115 products) 24 studies (A:0, B:9)
Papain
16.6 mg
Bovine Cartilage
100 mg
Pepsin
20 mg
Raw Veal Bone
50 mg
50 mg
Market median: 500.0mg (19 products)
Proprietary Blend
25 mg

Other Ingredients

Cellulose Vegetable Stearate Silica Water Ethylcellulose Ammonium Hydroxide Medium Chain Triglycerides Oleic Acid Sodium Alginate Stearic Acid
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Usage: As a dietary supplement, adults take 2 tablets 3 times daily, preferably on an empty stomach, or as directed by your healthcare professional.

Warnings & Precautions

Warning: If you have an allergy to shellfish, (including crab and shrimp) you should not use this product.

KEEP OUT OF REACH OF CHILDREN.

Tamper resistant package, do not use if outer seal is missing.

Formulation Notes

This product contains NO yeast, wheat, gluten, soy protein, milk/dairy, corn, sugar, starch, artificial coloring, preservatives or flavoring.

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)

Formula #7049

Metadata

Product Details

UPC / SKU3 10539 01154 6
DSLD Entry Date2014-02-26
Product TypeOther Combinations
FormTablet or Pill
DSLD ID30561
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.